NovoCure Limited Current Liabilities
NovoCure Limited (NVCR) had Current Liabilities of $220.71 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-23
- 2026-06-30: Liabilities, Current $220.71M.
- 2026-03-31: Liabilities, Current $217.58M.
- 2025-12-31: Liabilities, Current $223.23M.
- 2025-09-30: Liabilities, Current $776.01M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $220.71M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $217.58M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $223.23M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $776.01M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $749.63M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $743.30M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $756.39M 10-K · filed 2026-02-26 | $756.38M 10-K · filed 2025-02-27 |
| 2024-09-30 | $735.00M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $169.18M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $160.23M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $179.12M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $157.16M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $150.09M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $148.78M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $158.78M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $141.08M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $135.40M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $127.80M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $142.60M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $124.55M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $116.21M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $110.49M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $113.61M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $95.33M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $85.12M 10-Q/A · filed 2020-10-02 | |
| 2020-03-31 | $84.20M 10-Q/A · filed 2020-10-02 | |
| 2019-12-31 | $86.31M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $80.41M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $73.57M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $70.95M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $64.56M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $48.09M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $45.25M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $44.76M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $50.20M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $40.98M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $35.17M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $31.91M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $36.88M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $29.71M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $34.62M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $29.43M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $28.63M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $25.91M 10-Q · filed 2015-10-27 | |
| 2014-12-31 | $17.67M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |